Literature DB >> 21348796

Reversible MRI changes in prolonged status epilepticus: a case report.

Arunodaya Gujjar1, P C Jacob, Abdullah Al-Asmi, Nandhagopal Ramachandiran, Ammar Obaidi, Rajeev Jain.   

Abstract

MRI is an essential investigation in epilepsy and status epilepticus (SE) for determining the underlying cause. However, SE or prolonged seizures may themselves induce changes in the MRI resulting in difficulty in interpretation. This case report illustrates a patient who recovered completely from prolonged generalized idiopathic SE lasting more than 2 weeks and had transient bilateral external capsule, fronto-temporal, and insular cortical MRI changes. The mechanism of such MRI changes and their implications for survival even after prolonged SE are discussed.
Copyright © 2011 Informa Healthcare USA, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21348796     DOI: 10.3109/00207454.2011.556281

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  Claustrum damage and refractory status epilepticus following febrile illness.

Authors:  Stefano Meletti; Jana Slonkova; Iva Mareckova; Giulia Monti; Nicola Specchio; Petr Hon; Giada Giovannini; Vaclav Marcian; Annalisa Chiari; Petr Krupa; Nicola Pietrafusa; Dagmar Berankova; Michal Bar
Journal:  Neurology       Date:  2015-09-04       Impact factor: 9.910

2.  Unusual lesion in the bilateral external capsule following status epilepticus: a case report.

Authors:  Kyoung Jin Hwang; Key-Chung Park; Sung Sang Yoon; Tae-Beom Ahn
Journal:  J Epilepsy Res       Date:  2014-12-31

3.  New-Onset Refractory Status Epilepticus with Claustrum Damage: Definition of the Clinical and Neuroimaging Features.

Authors:  Stefano Meletti; Giada Giovannini; Giuseppe d'Orsi; Lisa Toran; Giulia Monti; Rahul Guha; Andreas Kiryttopoulos; Maria Grazia Pascarella; Tommaso Martino; Haris Alexopoulos; Martha Spilioti; Jana Slonkova
Journal:  Front Neurol       Date:  2017-03-27       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.